Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
About this item
Full title
Author / Creator
Xia, Xi , Ma, Quanfu , Li, Xiao , Ji, Teng , Chen, Pingbo , Xu, Hongbin , Li, Kezhen , Fang, Yong , Weng, Danhui , Weng, Yanjie , Liao, Shujie , Han, Zhiqiang , Liu, Ronghua , Zhu, Tao , Wang, Shixuan , Xu, Gang , Meng, Li , Zhou, Jianfeng and Ma, Ding
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
P21(WAF1/Cip1) binds to cyclin-dependent kinase complexes and inhibits their activities. It was originally described as an inhibitor of cancer cell proliferation. However, many recent studies have shown that p21 promotes tumor progression when accumulated in the cell cytoplasm. So far, little is known about the correlation between cytoplasmic p21 a...
Alternative Titles
Full title
Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_5f4a83d72395446384b7b709f4af464f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_5f4a83d72395446384b7b709f4af464f
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/1471-2407-11-399
